Context Therapeutics Aims For $20 Million IPO
sanjeri/E+ via Getty Images
Quick Take
Context Therapeutics (CNTX) has filed to raise $19.5 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical stage biopharma developing treatments for hormone-dependent…
